133 related articles for article (PubMed ID: 21224311)
1. Nail changes in a patient with leukaemia.
Bhaskar ME
BMJ; 2011 Jan; 342():c6439. PubMed ID: 21224311
[No Abstract] [Full Text] [Related]
2. A case of hydroxyurea-induced longitudinal melanonychia.
Utaş S; Kulluk P
Int J Dermatol; 2010 Apr; 49(4):469-70. PubMed ID: 20465711
[No Abstract] [Full Text] [Related]
3. Horizontal melanonychia.
Salman A; Eser A; Kaygusuz Atagunduz I; Ergun T
Actas Dermosifiliogr; 2017 Jun; 108(5):469-470. PubMed ID: 27543192
[No Abstract] [Full Text] [Related]
4. [Longitudinal melanonychia and hydroxyurea].
Pirard C; Michaux JL; Bourlond A
Ann Dermatol Venereol; 1994; 121(2):106-9. PubMed ID: 7979014
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal pigmented nail bands during hydroxyurea therapy.
Cakir B; Sucak G; Haznedar R
Int J Dermatol; 1997 Mar; 36(3):236-7. PubMed ID: 9159017
[No Abstract] [Full Text] [Related]
6. Imatinib mesylate causes palmoplantar hyperkeratosis and nail dystrophy in three patients with chronic myeloid leukaemia.
Deguchi N; Kawamura T; Shimizu A; Kitamura R; Yanagi M; Shibagaki N; Matsue H; Shimada S
Br J Dermatol; 2006 Jun; 154(6):1216-8. PubMed ID: 16704666
[No Abstract] [Full Text] [Related]
7. Hydroxyurea-induced fever in a patient with chronic myelogenous leukemia.
Tsurumi H; Goto H; Hara T; Moriwaki H
Int J Hematol; 2000 Oct; 72(3):386-7. PubMed ID: 11186000
[No Abstract] [Full Text] [Related]
8. Hydroxyurea-induced melanonychia concomitant with a dermatomyositis-like eruption.
Oh ST; Lee DW; Lee JY; Cho BK
J Am Acad Dermatol; 2003 Aug; 49(2):339-41. PubMed ID: 12894095
[TBL] [Abstract][Full Text] [Related]
9. Nail changes after chemotherapy.
Las Heras G; Juncà Piera J
Haematologica; 1998 Aug; 83(8):748. PubMed ID: 9793260
[No Abstract] [Full Text] [Related]
10. [Multiple keratosis induced by hydroxyurea].
Grange F; Couilliet D; Audhuy B; Krzisch S; Schlecht P; Guillaume JC
Ann Dermatol Venereol; 1995; 122(1-2):16-8. PubMed ID: 7668775
[TBL] [Abstract][Full Text] [Related]
11. Hydroxyurea in sickle cell disease.
Adams-Graves P; Heltsley C; Deitcher S
N Engl J Med; 1996 Feb; 334(5):333-4. PubMed ID: 8532043
[No Abstract] [Full Text] [Related]
12. Imatinib: a designer drug, another cutaneous complication.
Dickens E; Lewis F; Bienz N
Clin Exp Dermatol; 2009 Jul; 34(5):603-4. PubMed ID: 19486036
[TBL] [Abstract][Full Text] [Related]
13. Diffuse pigmentation of the palate.
Lewis DM
J Okla Dent Assoc; 2009 Nov; 100(8):24-5. PubMed ID: 19998620
[No Abstract] [Full Text] [Related]
14. [Symmetrical foot ulcer in chronic myeloid leukemia treated with hydroxyurea (Litalir)].
Reichenberger F
Praxis (Bern 1994); 1998 Oct; 87(41):1370-2. PubMed ID: 9828669
[No Abstract] [Full Text] [Related]
15. Reversible leg ulcer due to hydroxyurea in a case of chronic myeloid leukemia.
Tripathi AK; Ahmad R; Sawlani KK
J Assoc Physicians India; 2003 Oct; 51():1014-5. PubMed ID: 14719596
[TBL] [Abstract][Full Text] [Related]
16. Acquired generalized ichthyosis in chronic myeloid leukaemia.
Vinod KV; Verma S
Natl Med J India; 2014; 27(5):291. PubMed ID: 26037441
[No Abstract] [Full Text] [Related]
17. Multiple pigmented nail bands during hydroxyurea therapy: an uncommon finding.
Vomvouras S; Pakula AS; Shaw JM
J Am Acad Dermatol; 1991 Jun; 24(6 Pt 1):1016-7. PubMed ID: 1869665
[No Abstract] [Full Text] [Related]
18. Hydroxyurea induced leg ulcers.
Abhyankar D; Shende C; Saikia T; Advani SH
J Assoc Physicians India; 2000 Sep; 48(9):926-7. PubMed ID: 11198798
[TBL] [Abstract][Full Text] [Related]
19. [Anhidrosis during long-term hydroxyurea therapy in a patient with chronic myelogenous leukemia].
Takagi K; Nakamura T; Misaki H; Ueda T
Rinsho Ketsueki; 2000 Nov; 41(11):1214-9. PubMed ID: 11193442
[TBL] [Abstract][Full Text] [Related]
20. [Cutaneous complications of long-term hydroxyurea therapy].
Dem A; Diallo M; Gaye Fall MC; Dieng MM; Gaye M; Touré P
Ann Dermatol Venereol; 2008 Nov; 135(11):800-1. PubMed ID: 19061670
[No Abstract] [Full Text] [Related]
[Next] [New Search]
